ECR 2021 / C-10672
I 123 MIBG, Neuroblastoma and the Opsoclonus-myoclonus syndrome (OMS): Evaluation and Diagnosis
Type:
Educational Exhibit
Keywords:
Nuclear medicine, Paediatric, PACS, Diagnostic procedure, Neoplasia
Authors:
S. Kohanzad, D. Sadowsky, P. Gerard, J. Meshekow; Valhalla, NY/US
DOI:
10.26044/ecr2021/C-10672
References
- Kushner BH. Neuroblastoma: a disease requiring a multitude of imaging studies. Journal of Nuclear Medicine 2004; 45:1172-1188.
- Parisi MT, Hattner RS, Matthay KK, Berg BO, Sandler ED. Optimized diagnostic strategy for neuroblastoma in opsoclonus-myoclonus. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine 1993; 11:1922-1926.
- Hero B, Schleiermacher G. Update on pediatric opsoclonus myoclonus syndrome. Neuropediatrics 2013; 44:324-329.
- Jacobs A, Delree M, Desprechins B, et al. Consolidating the role of I-MIBG-scintigraphy in childhood neuroblastoma: Five years of clinical experience. Pediatric Radiology 1990; 20:157-159.
- Bouvier JF, Philip T, Chauvot P, et al. Pitfalls and solutions in neuroblastoma diagnosis using radioiodine MIBG: our experience about 50 cases. Progress in Clinical and Biological Research 1988;271:707-720.